Skip to content
Alpha Edge Investing

Alpha Edge Investing

"Investors operate with limited funds and limited intelligence, they don’t need to know everything. As long as they understand better than others, they have an edge.” – George Soros

  • Home
  • Earnings Updates/ Corporate Actions
  • Research – Equities
  • Research – Fixed Income/ Bonds
  • Research – Unit Trust/ ETF
  • News
  • My Opinions/ Views
  • Others
  • About Me
  • Contact
  • Disclaimer
  • Community and Support Forums
  • Toggle search form

DBS: Frencken Group Ltd – Add Target Price $1.75 (Previous $1.72)

Posted on August 15, 2022August 15, 2022 By alanyeo No Comments on DBS: Frencken Group Ltd – Add Target Price $1.75 (Previous $1.72)

Expecting hoh revenue improvement

  • 1H22 revenue (S$389m) was in line at 97% of our S$402m forecast and formed 46% of our/Bloomberg consensus full-year forecast.
  • 1H22 net profit (S$26.1m) was in line at 102% of our S$25.7m forecast and formed 47%/46% of our/Bloomberg consensus full-year forecast.
  • Our TP is raised slightly to S$1.75 (previously S$1.72).
1H22 results: in line with our expectation

1H22 revenue rose 3.6% yoy to S$389m. The Mechatronics division revenue (87.3% of
1H22 revenue) grew 6.2% yoy while the Automotive division (12.5% of 1H22 revenue) saw
a 11.5% yoy revenue decline. 1H22 revenue (S$389m) was in line at 97% of our S$402m
forecast and formed 46% of our/Bloomberg consensus full-year forecast. 1H22 net profit
fell 16.6% yoy to S$26.1m. 1H22 net profit (S$26.1m) was in line at 102% of our S$25.7m
forecast and formed 47%/46% of our/Bloomberg consensus full-year forecast. 1H22 gross
profit margin fell 1.79% pts yoy and 0.58% pts hoh to 15.63% (1H21: 17.42%, 2H21:
16.21%). The decline in the gross profit margin was due to inflationary cost pressures and
additional depreciation expenses as the group invested to upgrade its machineries and
expanded capacity globally.

2H22F outlook: management expects hoh revenue growth

Management guided that 2H22F revenue is expected to post a moderate increase
compared with 1H22. It expects the semiconductor, medical, analytical and life sciences
and automotive segments to post hoh increases in revenue, but projects the industrial
automation segment to see a hoh decrease in revenue. On the margin front, Frencken has
managed to pass on some of the cost increase to customers. Some of these benefits may
be offset by the group’s ongoing investments in its facilities in Europe, Malaysia and
Singapore to pursue additional revenue opportunities for FY23F and beyond.

Reiterate Add on growth potential

We reiterate our Add call (driven by its earnings growth potential) and our TP (based on
FY23F EPS forecast) is raised slightly to S$1.75 (previously S$1.72) as the +1 s.d. P/E
multiple over Jan 17 to Aug 22 has risen to 11.4x (previously, the +1 s.d. P/E multiple over
Jan 17 to Jun 22 was 11.2x). Downside risks are potential production disruptions arising
from Covid-19 infections in its workforce and further cost pressures from higher raw
material costs. Potential re-rating catalysts are increased wallet share with customers and
clinching new customers.

FrenckenClick here to Download Full Report in PDF

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
Research - Equities Tags:Frencken Group

Post navigation

Previous Post: CIMB: Q&M Dental Group – Add Target Price $0.73
Next Post: CIMB: Pentamaster – Add Target Price HK$1.45 (Previous HK$1.60)

Related Posts

DBS: ASEAN Tech Research - Equities
UOBKH: Tech Manufacturers – Singapore (Overweight) Research - Equities
UOBKH: STRATEGY – SINGAPORE Research - Equities
UOBKH: Singapore Strategy Research - Equities
UOBKH: Frencken Group – Buy Target Price $1.60 Research - Equities
DBS: Frencken Group Ltd – Hold Target Price $1.36 Research - Equities
UOBKH: Monthly Review and Outlook – Singapore Research - Equities
UOBKH: Singapore Strategy – Alpha Picks Research - Equities
UOBKH: Singapore Technology Manufacturers (Overweight) Research - Equities
KE: Singapore Technology (Positive) – Venture, AEM, UMS, Frencken, Aztech, Valuetronics Research - Equities
KE: Invest ASEAN SG 2022 – Navigating growth & inflation Research - Equities
UOBKH: Singapore Market Strategy – STI 2022 YEAR-END TARGET: 3,390 Research - Equities

Leave a Reply

You must be logged in to post a comment.

Login

Log In
Register Lost Password
Get new posts by email
Chat on WhatsApp
  • Earnings Updates/ Corporate Actions
  • My Opinions/ Views
  • News
  • Others
  • Research – Equities
  • Research – Fixed Income/ Bonds
  • Research – Unit Trusts/ ETF

Copyright © 2023 Alpha Edge Investing.

Powered by PressBook Grid Blogs theme